Aldevron Names Marc Wolff CFO

Marc Wolff has been named Chief Financial Officer of Aldevron, a provider of plasmid DNA manufacturing, protein production and antibody discovery services. Mr. Wolff will lead the global finance and accounting team across all Aldevron sites in the U.S. and Europe.

Prior to joining Sancilio Pharmaceuticals Company, Inc., Mr. Wolff served as Chief Financial Officer of JHP Pharmaceuticals, LLC, or JHP, a fully-integrated specialty pharmaceutical company that acquires, develops, manufactures and sells branded and generic sterile products. At JHP, he oversaw the successful completion of the merger with Par Pharmaceutical. Prior to then, Mr. Wolff served in leadership roles in general management and finance at ReSearch Pharmaceutical Services, Catalent, and Cardinal Health.